16 insiders reported 107 Form 4 transactions for Praxis Precision Medicines, Inc. (PRAX) over the past 18 months (most recent 2026-06-26). Recent activity: DeSimone Jill (Director) Buy 8,566 shares, DeSimone Jill (Director) Sell 837 shares, DeSimone Jill (Director) Sell 10 shares, DeSimone Jill (Director) Sell 120 shares, DeSimone Jill (Director) Sell 320 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | DeSimone Jill | Director | Buy | 8,566 | $379,046 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 837 | $264,245 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 10 | $3,014 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 120 | $36,375 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 320 | $97,699 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 683 | $209,522 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 1,240 | $382,221 |
| 2026-06-26 | DeSimone Jill | Director | Buy | 3,034 | $446,908 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 1,750 | $544,056 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 2,854 | $890,203 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 1,004 | $314,081 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 504 | $158,086 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 1,279 | $402,758 |
| 2026-06-26 | DeSimone Jill | Director | Sell | 999 | $309,074 |
| 2026-06-12 | YOUNG WILLIAM D | Director | Buy | 1,371 | $0 |
| 2026-06-12 | KINDLER JEFFREY B | Director | Buy | 1,371 | $0 |
| 2026-06-12 | Norden Gregory | Director | Buy | 1,371 | $0 |
| 2026-06-12 | Arbuckle Stuart A | Director | Buy | 1,371 | $0 |
| 2026-06-12 | Chodakewitz Jeffrey | Director | Buy | 1,371 | $0 |
| 2026-06-12 | DeSimone Jill | Director | Buy | 1,371 | $0 |
| 2026-06-12 | MITCHELL DEAN J | Director | Buy | 1,371 | $0 |
| 2026-06-12 | Cudkowicz Merit Ester | Director | Buy | 1,371 | $0 |
| 2026-05-19 | Mastrocola Lauren | Principal Accounting Officer | Buy | 127 | $21,329 |
| 2026-05-19 | Souza Marcio | Chief Executive Officer | Buy | 126 | $21,161 |
| 2026-05-19 | Sniecinski Megan | Chief Operating Officer | Buy | 89 | $14,947 |
Source: SEC Form 4 filings · as of 2026-06-26